Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-07 17:27:41 - browse：4

A product image of the Cue reader COVID-19 home use test — Businesswire via AP

The Food and Drug Administration warned consumers Monday to not use Cue Health’s at-home Covid-19 tests. This follows an FDA warning letter to the company last week that said Cue was not following the conditions stipulated in the emergency use authorizations for its tests.

The FDA letters said the tests could give false results. Specifically, the agency said that the company had changed how the electrochemical signals within the test device were generated, received, and interpreted — changes the FDA has not authorized. These changes decreased the stability of the tests and might lead to false results, the agency said.

The FDA warnings come near what might be the end of a spectacularly bumpy ride for the company. When Cue went public in 2021, it was valued at nearly $3 billion. It supplied tests for the NBA’s 2020 “bubble,” leading a Trump administration official to proclaim that if the test was “good enough for LeBron,” the administration would bring it to the American people — and it did, in a $481 million deal.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Hospitals are piloting generative AI tools as regulators play catch

knowledge

WSS

Why don't Americans have at

Hospitals are piloting generative AI tools as regulators play catch

WATCH: Why do our ears pop?

Artificial intelligence use in health care faces greater scrutiny in 2024

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Study gives hint on South Asians’ higher risk of cardiovascular disease

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Medicare details structure of new drug price negotiation program

Latigo launches with $135 million for Vertex

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Ebola vaccine can save some who are already sick, per new study

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Surprise medical billing ban raises prices elsewhere

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Flagship Pioneering startup Sonata Therapeutics lays off 21

What does generative AI mean for health care? We asked experts

Artificial intelligence use in health care faces greater scrutiny in 2024

entertainment

Ebola vaccine can save some who are already sick, per new study

STAT Boddities: What happens to the brain when we get scared?

Congress considering partial increase for doctor pay in Medicare

WATCH: Why do our ears pop?

Researchers tackle phage therapy hurdles for wider adoption

Too many hospitalized Covid

hotspot

knowledge

explore

Wikipedia